arrow_back Back to App

Reaffirming Federal Authority Over Reproductive Health Products

This resolution confirms that federal law takes precedence over state law regarding access to reproductive health products, such as medications. This means states cannot ban or restrict access to products approved by the federal Food and Drug Administration (FDA). The aim is to ensure citizens have consistent access to these products, regardless of state regulations.
Key points
Federal law, not state law, governs the availability of reproductive health products, including medications.
States cannot enact laws that restrict access to products approved by the federal Food and Drug Administration (FDA).
The U.S. Attorney General has the authority to take legal action against states attempting to limit access to these products.
article Official text account_balance Process page
Adopted
Citizen Poll
No votes cast
Additional Information
Print number: 117_HRES_1434
Sponsor: Rep. Jones, Mondaire [D-NY-17]
Process start date: 2022-10-14
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Reaffirming the preemptive authority of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) and the Public Health Service Act (42 U.S.C. 201 et seq.) (including regulations thereunder) with respect to State laws that inhibit access to or use of any reproductive health product.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HRES_1434.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-10-14.

What are the main provisions?

Key points include:

  • Federal law, not state law, governs the availability of reproductive health products, including medications.
  • States cannot enact laws that restrict access to products approved by the federal Food and Drug Administration (FDA).
  • The U.S. Attorney General has the authority to take legal action against states attempting to limit access to these products.
What is the specific legal status?

The current status is Adopted.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Jones, Mondaire [D-NY-17].

What is the latest detailed status?

The latest detailed status is: Pursuant to the provisions of H. Res. 1529, H. Res. 1434 is considered passed House.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

CATEGORIES

Health Courts and Law